Financial statement of The Jordanian Pharmaceutical Manufacturing showed that the company’s losses rose by 40.17% to JOD 5.7 million in the first quarter of 2014 compared with JOD 4.08 million in the same period of 2013.

Losses per share hit JOD 0.29 in H1-14 against JOD 0.20 in H1-13.

Total sales profits declined by 60.2% to JOD 2.27 million in the first six months this year compared with 5.72 million in the same period of 2013.

The company’s losses increased by 233.87% in the second quarter of 2014 to reach JOD 4.06 million compared with JOD 1.21 million in the same quarter last year.